| HPO |
HP:0410300 |
Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine |
"The inability to synthesize postvaccination antibodies against a pneumococcus antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410299 |
| HPO |
HP:0410301 |
Partial absence of specific antibody response to unconjugated pneumococcus vaccine |
"A reduced ability to synthesize postvaccination antibodies against a pneumococcus antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410299 |
| HPO |
HP:0410302 |
Decreased specific antibody response to protein-conjugated polysaccharide vaccine |
"A reduced ability to synthesize postvaccination antibodies against protein-conjugated polysaccharides in vaccines, as measured by antibody titer determination following vaccination." [PMID:26018535] |
— |
HP:0032140 |
| HPO |
HP:0410303 |
Complete or near-complete absence of specific antibody response to Haemophilus influenzae type b (Hib) vaccine |
"The inability to synthesize postvaccination antibodies against a Haemophilus influenzae type b (Hib) antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410302 |
| HPO |
HP:0410304 |
Complete or near-complete absence of specific antibody response to meningococcus vaccine |
"The inability to synthesize postvaccination antibodies against a meningococcus antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410302 |
| HPO |
HP:0410305 |
Partial absence of specific antibody response to Haemophilus influenzae type b (Hib) vaccine |
"A reduced ability to synthesize postvaccination antibodies against a Haemophilus influenzae type b (Hib) antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410302 |
| HPO |
HP:0410306 |
Partial absence of specific antibody response to meningococcus vaccine |
"A reduced ability to synthesize postvaccination antibodies against a meningococcus antigen, as measured by antibody titer determination following vaccination." [] |
— |
HP:0410302 |
| HPO |
HP:0410307 |
Positive stool methadone test |
"Detection of methadone and its metabolites in the stool." [] |
— |
HP:0500097 |
| HPO |
HP:0410308 |
Decreased specific antibody response to infection |
"A reduced ability to synthesize antibodies against antigens from an infectious agent or pathogen (such as bacteria, viruses, parasites, etc.), as measured by antibody titer determination following infection." [] |
— |
HP:0012475 |
| HPO |
HP:0410309 |
Alpha-aminoadipic aciduria |
"A increased concentration of alpha-aminoadipic acid in the urine." [https://orcid.org/0000-0002-8169-9049, PMID:117247] |
— |
HP:0003215, HP:0033098 |
| HPO |
HP:0410310 |
Abnormality of neutrophil morphology in CSF |
"An abnormal form or size of neutrophils in the cerebrospinal fluid." [https://orcid.org/0000-0002-8169-9049] |
— |
HP:0002921 |
| HPO |
HP:0410311 |
Hyposegmentation of neutrophil nuclei in CSF |
"Hyposegmented (hypolobulated) or bilobed neutrophil nuclei in the cerebrospinal fluid." [https://orcid.org/0000-0002-8169-9049] |
— |
HP:0410310 |
| HPO |
HP:0410312 |
Hypersegmentation of neutrophil nuclei in CSF |
"An excessive division of the lobes of the nucleus of a neutrophil in the cerebrospinal fluid." [https://orcid.org/0000-0002-8169-9049] |
— |
HP:0410310 |
| HPO |
HP:0410313 |
Abnormal urinary 1-methylhistidine concentration |
"Abnormal concentration of 1-methylhistidine in the urine." [https://orcid.org/0000-0002-8169-9049] |
— |
HP:0033097 |
| HPO |
HP:0410314 |
Decreased urinary 1-methylhistidine |
"Decreased concentration of 1-methylhistidine in the urine." [https://orcid.org/0000-0002-8169-9049] |
— |
HP:0410313 |
| HPO |
HP:0410315 |
Increased urinary 1-methylhistidine |
"Increased concentration of 1-methylhistidine in the urine." [https://orcid.org/0000-0002-8169-9049] |
— |
HP:0410313 |
| HPO |
HP:0410316 |
Abnormal urinary 3-methylhistidine level |
"Abnormal amount of 3-methylhistidine in the urine." [https://orcid.org/0000-0002-8169-9049, PMID:6780020, PMID:6790901] |
3-Methylhistidine is an analog of histidine found mainly in skeletal muscle. The rate of myofibrillar protein breakdown may be estimated from the urinary excretion of 3-methylhistidine. This amino acid is formed by the methylation of peptide-bound histidine in actin and myosin, is excreted in the urine when these proteins are broken down, and is not reused for protein synthesis. |
HP:0033097 |
| HPO |
HP:0410317 |
Increased urinary 3-methylhistidine |
"Increased concentration of 3-methylhistidine in the urine." [https://orcid.org/0000-0002-8169-9049, PMID:6780020, PMID:6790901] |
— |
HP:0410316 |
| HPO |
HP:0410318 |
Decreased urinary 3-methylhistidine |
"Decreased concentration of 3-methylhistidine in the urine." [https://orcid.org/0000-0002-8169-9049, PMID:6790901] |
— |
HP:0410316 |
| HPO |
HP:0410319 |
Alpha-gal allergy |
"Hypersensitivity in form of an adverse immune reaction against alpha-gal." [] |
— |
HP:0012393 |
| HPO |
HP:0410320 |
Animal protein allergy |
"Hypersensitivity in form of an adverse immune reaction against animal proteins." [] |
— |
HP:0012393 |
| HPO |
HP:0410321 |
Animal dander allergy |
"Hypersensitivity in form of an adverse immune reaction against animal dander." [] |
— |
HP:0410320 |
| HPO |
HP:0410322 |
Bacteria allergy |
"Hypersensitivity in form of an adverse immune reaction against bacteria." [] |
— |
HP:0012393 |
| HPO |
HP:0410323 |
Drug allergy |
"Hypersensitivity in form of an adverse immune reaction against drugs." [] |
— |
HP:0012393 |
| HPO |
HP:0410324 |
Dust mite allergy |
"Hypersensitivity in form of an adverse immune reaction against dust mites." [] |
— |
HP:0012393 |